Pixium Vision Announces the First Successful Implantation and Activation of IRIS® II, 150 Electrode Bionic Vision System, in the UK
PARIS & LONDON--(BUSINESS WIRE)--Regulatory News: Pixium Vision (Paris:PIX) (FR0011950641 – PIX, “Pixium”), a company developing innovative bionic vision systems with the intention to allow patients who have lost their sight to lead more independent lives, announces the first successful implantation and activation of IRIS® II in the UK. This epi-retinal implant with 150 electrodes is intended for patients who have lost sight as a result of retinitis pigmentosa (RP). The first implant of IRIS® I
